Literature DB >> 33047319

Milk thistle seed cold press oil attenuates markers of the metabolic syndrome in a mouse model of dietary-induced obesity.

Hsin-Hsueh Shen1,2, Ragin Alex3, Lars Bellner3, Marco Raffaele1,4, Maria Licari1,4, Luca Vanella4, David E Stec5, Nader G Abraham1,3.   

Abstract

Milk thistle cold press oil (MTO) is an herbal remedy derived from Silybum marianum which contains a low level of silymarin and mixture of polyphenols and flavonoids. The effect of MTO on the cardiovascular and metabolic complications of obesity was studied in mice that were fed a high-fat diet (HFD) for 20 weeks and treated with MTO for the final 8 weeks of the diet. MTO treatment attenuated HFD-induced obesity, fasting hyperglycemia, hypertension, and induced markers of mitochondrial fusion and browning of white adipose. Markers of inflammation were also attenuated in both adipose and the liver of MTO-treated mice. In addition, MTO resulted in the improvement of liver fibrosis. These results demonstrate that MTO has beneficial actions to attenuate dietary obesity-induced weight gain, hyperglycemia, hypertension, inflammation, and suggest that MTO supplementation may prove beneficial to patients exhibiting symptoms of metabolic syndrome. PRACTICAL APPLICATIONS: Natural supplements are increasingly being considered as potential therapies for many chronic cardiovascular and metabolic diseases. Milk thistle cold press oil (MTO) is derived from Silybum marianum which is used as a dietary supplement in different parts of the world. The results of the present study demonstrate that MTO supplementation normalizes several metabolic and cardiovascular complications arising from dietary-induced obesity. MTO supplementation also had anti-inflammatory actions in the adipose as well as the liver. These results suggest that supplementation of MTO into the diet of obese individuals may afford protection against the worsening of cardiovascular and metabolic disease and improve inflammation and liver fibrosis.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  heme oxygenase; metabolism; mitochondria; type II diabetes

Mesh:

Year:  2020        PMID: 33047319      PMCID: PMC7770619          DOI: 10.1111/jfbc.13522

Source DB:  PubMed          Journal:  J Food Biochem        ISSN: 0145-8884            Impact factor:   2.720


  57 in total

1.  Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity.

Authors:  Jonathan R Brestoff; Brian S Kim; Steven A Saenz; Rachel R Stine; Laurel A Monticelli; Gregory F Sonnenberg; Joseph J Thome; Donna L Farber; Kabirullah Lutfy; Patrick Seale; David Artis
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

Review 2.  Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis.

Authors:  Magalí Barchuk; Laura Schreier; Gabriela Berg; Verónica Miksztowicz
Journal:  Horm Mol Biol Clin Investig       Date:  2018-09-01

Review 3.  Peripheral adrenergic receptors in hypertension.

Authors:  M C Michel; O E Brodde; P A Insel
Journal:  Hypertension       Date:  1990-08       Impact factor: 10.190

4.  Glucose deprivation induces heme oxygenase-1 gene expression by a pathway independent of the unfolded protein response.

Authors:  Se-Ho Chang; Ione Barbosa-Tessmann; Chin Chen; Michael S Kilberg; Anupam Agarwal
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

5.  Modulation of mitochondrial capacity and angiogenesis by red wine polyphenols via estrogen receptor, NADPH oxidase and nitric oxide synthase pathways.

Authors:  Lucie Duluc; Caroline Jacques; Raffaella Soleti; Francesco Iacobazzi; Gilles Simard; Ramaroson Andriantsitohaina
Journal:  Int J Biochem Cell Biol       Date:  2013-01-16       Impact factor: 5.085

6.  NOV/CCN3: A New Adipocytokine Involved in Obesity-Associated Insulin Resistance.

Authors:  Cécile Martinerie; Marie Garcia; Thi Thu Huong Do; Bénédicte Antoine; Marthe Moldes; Guillaume Dorothee; Chantal Kazazian; Martine Auclair; Marion Buyse; Tatiana Ledent; Pierre-Olivier Marchal; Maria Fesatidou; Adrien Beisseiche; Haruhiko Koseki; Shuichi Hiraoka; Christos Evangelos Chadjichristos; Bertrand Blondeau; Raphael Georges Denis; Serge Luquet; Bruno Fève
Journal:  Diabetes       Date:  2016-06-09       Impact factor: 9.461

7.  Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice.

Authors:  E Csongradi; J M Docarmo; J H Dubinion; T Vera; D E Stec
Journal:  Int J Obes (Lond)       Date:  2011-04-05       Impact factor: 5.095

8.  Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor.

Authors:  Ming Gu; Ping Zhao; Jinwen Huang; Yuanyuan Zhao; Yahui Wang; Yin Li; Yifei Li; Shengjie Fan; Yue-Ming Ma; Qingchun Tong; Li Yang; Guang Ji; Cheng Huang
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

Review 9.  The Beige Adipocyte as a Therapy for Metabolic Diseases.

Authors:  Fernando Lizcano
Journal:  Int J Mol Sci       Date:  2019-10-12       Impact factor: 5.923

Review 10.  Therapeutic Efficacy of Stem Cells Transplantation in Diabetes: Role of Heme Oxygenase.

Authors:  Marco Raffaele; Giovanni Li Volti; Ignazio A Barbagallo; Luca Vanella
Journal:  Front Cell Dev Biol       Date:  2016-08-05
View more
  3 in total

Review 1.  A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block.

Authors:  Nikolaos P E Kadoglou; Chrystalla Panayiotou; Michail Vardas; Nikolaos Balaskas; Nikolaos G Kostomitsopoulos; Alexandra K Tsaroucha; Georgia Valsami
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

Review 2.  High Fat Rodent Models of Type 2 Diabetes: From Rodent to Human.

Authors:  Nicole L Stott; Joseph S Marino
Journal:  Nutrients       Date:  2020-11-27       Impact factor: 5.717

3.  Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin.

Authors:  Marco Raffaele; Kristina Kovacovicova; Jan Frohlich; Oriana Lo Re; Sebastiano Giallongo; Jude A Oben; Martin Faldyna; Lenka Leva; Antonino Giulio Giannone; Daniela Cabibi; Manlio Vinciguerra
Journal:  Cell Commun Signal       Date:  2021-04-08       Impact factor: 5.712

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.